Related Experiment Video
Updated: Mar 6, 2026

Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
H5N1 Virus Plastic Antibody Based on Molecularly Imprinted Polymers
Chak Sangma1, Peter A Lieberzeit2, Wannisa Sukjee3
1Faculty of Science, Department of Chemistry, Center for Advanced Studies in Nanotechnology and Its Applications in Chemical, Food and Agricultural Industries, Kasetsart University, 50 Ngam Wong Wan Rd., Chatuchak, Bangkok, 10900, Thailand. fscicsm@ku.ac.th.
Researchers developed a novel method to create H5N1 antibodies using polymeric materials and inactivated virus. This technique allows for antibody production in low-biosafety labs, offering a stable and easily stored alternative to traditional antibodies.
Area of Science:
- Biomaterials Science
- Immunotechnology
- Virology
Background:
- Traditional antibody production for influenza A, especially highly pathogenic strains like H5N1, requires specific hosts or cell cultures and stringent biosafety measures.
- Biomolecular antibodies necessitate careful handling and cold chain storage, increasing logistical challenges.
- Pathogenic virus handling, such as for H5N1, demands high-level biosafety laboratory environments.
Purpose of the Study:
- To develop an alternative method for producing H5N1 antibodies using polymeric materials.
- To enable antibody production in a low-level biosafety setting.
- To create a stable, room-temperature storable antibody alternative.
Main Methods:
- Utilizing inactivated H5N1 virus for antibody imprinting.
- Employing molecularly imprinted polymers (MIPs) by imprinting the whole virus onto a polymer surface.
- Conducting the production process in a low-level biosafety laboratory.
Main Results:
- Successfully generated H5N1-imprinted polymers (MIPs) with antibody-like properties.
- Demonstrated that these MIPs can recognize the H5N1 virus.
- Observed that the MIPs exhibit significant antibody activity.
- Established that the MIPs are not biomaterials and can be stored at room temperature.
Conclusions:
- Molecularly imprinted polymers offer a viable, non-biomaterial alternative for H5N1 "antibody" production.
- This method significantly reduces the need for specialized handling and high-level biosafety containment.
- The room-temperature stability of these MIPs presents a practical advantage over conventional antibodies.

